Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors. / Szymańska, Ewa; Nielsen, Birgitte; Johansen, Tommy Nørskov; Cuñado Moral, Anna Maria; Pickering, Darryl S; Szczepańska, Katarzyna; Mickowska, Anna; Kieć-Kononowicz, Katarzyna.

In: European Journal of Medicinal Chemistry, Vol. 138, 2017, p. 874-883.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Szymańska, E, Nielsen, B, Johansen, TN, Cuñado Moral, AM, Pickering, DS, Szczepańska, K, Mickowska, A & Kieć-Kononowicz, K 2017, 'Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors', European Journal of Medicinal Chemistry, vol. 138, pp. 874-883. https://doi.org/10.1016/j.ejmech.2017.07.007

APA

Szymańska, E., Nielsen, B., Johansen, T. N., Cuñado Moral, A. M., Pickering, D. S., Szczepańska, K., ... Kieć-Kononowicz, K. (2017). Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors. European Journal of Medicinal Chemistry, 138, 874-883. https://doi.org/10.1016/j.ejmech.2017.07.007

Vancouver

Szymańska E, Nielsen B, Johansen TN, Cuñado Moral AM, Pickering DS, Szczepańska K et al. Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors. European Journal of Medicinal Chemistry. 2017;138:874-883. https://doi.org/10.1016/j.ejmech.2017.07.007

Author

Szymańska, Ewa ; Nielsen, Birgitte ; Johansen, Tommy Nørskov ; Cuñado Moral, Anna Maria ; Pickering, Darryl S ; Szczepańska, Katarzyna ; Mickowska, Anna ; Kieć-Kononowicz, Katarzyna. / Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors. In: European Journal of Medicinal Chemistry. 2017 ; Vol. 138. pp. 874-883.

Bibtex

@article{41bb800ccce64ca292caff186379d00b,
title = "Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors",
abstract = "In order to map out molecular determinants for the competitive blockade of AMPA receptor subtypes, a series of racemic aryl-substituted phenylalanines was synthesized and pharmacologically characterized in vitro at native rat ionotropic glutamate receptors. Most of the compounds showed micromolar affinity and preference for AMPA receptors. Individual stereoisomers of selected compounds were further evaluated at recombinant homomeric rat GluA2 and GluA3 receptors. The most potent compound, (–)-2-amino-3-(6-chloro-2',5'-dihydroxy-5-nitro-[1,1'-biphenyl]-3-yl)propanoic acid, the expected R-isomer showing Ki of 1.71 µM at the GluA2 subtype, was found to competitively antagonize GluA2(Q)i receptors in TEVC electrophysiological experiments (Kb = 2.13 µM). Molecular docking experiments allowed us to compare two alternative antagonist binding modes for the synthesized phenylalanines at the GluA2 binding core, showing the direction for further structural modifications.",
author = "Ewa Szymańska and Birgitte Nielsen and Johansen, {Tommy N{\o}rskov} and {Cu{\~n}ado Moral}, {Anna Maria} and Pickering, {Darryl S} and Katarzyna Szczepańska and Anna Mickowska and Katarzyna Kieć-Kononowicz",
year = "2017",
doi = "10.1016/j.ejmech.2017.07.007",
language = "English",
volume = "138",
pages = "874--883",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson",

}

RIS

TY - JOUR

T1 - Pharmacological characterization and binding modes of novel racemic and optically active phenylalanine-based antagonists of AMPA receptors

AU - Szymańska, Ewa

AU - Nielsen, Birgitte

AU - Johansen, Tommy Nørskov

AU - Cuñado Moral, Anna Maria

AU - Pickering, Darryl S

AU - Szczepańska, Katarzyna

AU - Mickowska, Anna

AU - Kieć-Kononowicz, Katarzyna

PY - 2017

Y1 - 2017

N2 - In order to map out molecular determinants for the competitive blockade of AMPA receptor subtypes, a series of racemic aryl-substituted phenylalanines was synthesized and pharmacologically characterized in vitro at native rat ionotropic glutamate receptors. Most of the compounds showed micromolar affinity and preference for AMPA receptors. Individual stereoisomers of selected compounds were further evaluated at recombinant homomeric rat GluA2 and GluA3 receptors. The most potent compound, (–)-2-amino-3-(6-chloro-2',5'-dihydroxy-5-nitro-[1,1'-biphenyl]-3-yl)propanoic acid, the expected R-isomer showing Ki of 1.71 µM at the GluA2 subtype, was found to competitively antagonize GluA2(Q)i receptors in TEVC electrophysiological experiments (Kb = 2.13 µM). Molecular docking experiments allowed us to compare two alternative antagonist binding modes for the synthesized phenylalanines at the GluA2 binding core, showing the direction for further structural modifications.

AB - In order to map out molecular determinants for the competitive blockade of AMPA receptor subtypes, a series of racemic aryl-substituted phenylalanines was synthesized and pharmacologically characterized in vitro at native rat ionotropic glutamate receptors. Most of the compounds showed micromolar affinity and preference for AMPA receptors. Individual stereoisomers of selected compounds were further evaluated at recombinant homomeric rat GluA2 and GluA3 receptors. The most potent compound, (–)-2-amino-3-(6-chloro-2',5'-dihydroxy-5-nitro-[1,1'-biphenyl]-3-yl)propanoic acid, the expected R-isomer showing Ki of 1.71 µM at the GluA2 subtype, was found to competitively antagonize GluA2(Q)i receptors in TEVC electrophysiological experiments (Kb = 2.13 µM). Molecular docking experiments allowed us to compare two alternative antagonist binding modes for the synthesized phenylalanines at the GluA2 binding core, showing the direction for further structural modifications.

U2 - 10.1016/j.ejmech.2017.07.007

DO - 10.1016/j.ejmech.2017.07.007

M3 - Journal article

VL - 138

SP - 874

EP - 883

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -

ID: 180855900